VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $33,063 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,692,429 | $288,444,000 | 51.94% |
| Trustees of Columbia University in the City of New York | 183,821 | $7,923,000 | 9.60% |
| RA Capital Management | 11,120,973 | $479,314,000 | 7.23% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,074,658 | $46,318,000 | 6.00% |
| Sarissa Capital Management LP | 707,010 | $30,472,000 | 2.92% |
| SECTORAL ASSET MANAGEMENT INC | 535,259 | $23,070,000 | 1.75% |
| Woodline Partners LP | 1,153,267 | $49,706,000 | 1.10% |
| Artal Group S.A. | 550,000 | $23,705,000 | 0.42% |
| Orbimed Advisors | 833,333 | $35,917,000 | 0.34% |
| Laurion Capital Management LP | 585,667 | $25,242,000 | 0.14% |